Cargando…

Estimated Atherosclerotic Cardiovascular Disease Risk: Disparities and Severe COVID-19 Outcomes (from the National COVID Cohort Collaborative)

Although cardiovascular disease risk factors relate to COVID-19, the association of estimated atherosclerotic cardiovascular disease (ASCVD) risk with severe COVID-19 is not established. We examined the relation of the pooled-cohort ASCVD risk score to severe COVID-19 among 28,646 subjects from the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arif, Yousif A., Stefanko, Alexa M., Garcia, Nicholas, Beshai, David A., Fan, Wenjun, Wong, Nathan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513339/ https://www.ncbi.nlm.nih.gov/pubmed/36175254 http://dx.doi.org/10.1016/j.amjcard.2022.08.011

Ejemplares similares

RELATION OF 10-YEAR ASCVD RISK SCORE WITH SEVERE COVID-19 OUTCOMES
por: Arif, Yousif, et al.
Publicado: (2022)

National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020
por: Lu, Yuan, et al.
Publicado: (2023)

Racial and geographic disparities in influenza vaccination in the U.S. among individuals with atherosclerotic cardiovascular disease: Renewed importance in the setting of COVID-19
por: Al Rifai, Mahmoud, et al.
Publicado: (2021)

Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States
por: Klimchak, Alexa C., et al.
Publicado: (2020)

Should adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease?
por: Zhao, Yanglu, et al.
Publicado: (2015)

Estimating the number of preventable cardiovascular disease events in the United States using the EMPA-REG OUTCOME trial results and National Health and Nutrition Examination Survey
por: Wong, Nathan D, et al.
Publicado: (2020)

Racial and Geographic Disparities in Internet Use in the United States Among Patients with Atherosclerotic Cardiovascular Disease
por: Al Rifai, Mahmoud, et al.
Publicado: (2020)

Is Lipoprotein(a) the Most Important Predictor of Residual Atherosclerotic Cardiovascular Disease Risk?
por: Wong, Nathan D.
Publicado: (2022)

Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetes
por: Cai, Xiaoling, et al.
Publicado: (2022)

Evolution of Coronary Calcium Screening for Assessment of Atherosclerotic Cardiovascular Disease Risk and Role in Preventive Cardiology
por: Wong, Nathan D.
Publicado: (2022)

Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial Infarction
por: Ohm, Joel, et al.
Publicado: (2023)

The National COVID Cohort Collaborative: Clinical Characterization and Early Severity Prediction
por: Bennett, Tellen D., et al.
Publicado: (2021)

Gender Disparities in Health Resource Utilization in Patients with Atherosclerotic Cardiovascular Disease: A Retrospective Cross-Sectional Study
por: Shen, Xian, et al.
Publicado: (2019)

Exploring Gender Disparities in the Prevalence and Clinical Characteristics of Atherosclerotic Cranial Stenosis
por: Alqahtani, Saeed A
Publicado: (2023)

COVID-19 Pandemic Experience:: A Collaborative Approach to Eliminate Health Disparities
por: Gwanmesia, Eunice, et al.
Publicado: (2022)

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
por: Hageman, Steven H J, et al.
Publicado: (2022)

Inflammation in atherosclerotic cardiovascular disease
por: Shah, Prediman K., et al.
Publicado: (2019)

Atherosclerotic Cardiovascular Risk in Japan
por: Nojiri, Shuko, et al.
Publicado: (2017)

Comparison of Innovative and Traditional Cardiometabolic Indices in Estimating Atherosclerotic Cardiovascular Disease Risk in Adults
por: Huang, Ya-Chin, et al.
Publicado: (2021)

Sex Associations Between Air Pollution and Estimated Atherosclerotic Cardiovascular Disease Risk Determination
por: Vallée, Alexandre
Publicado: (2023)

Reducing the burden of cardiovascular diseases: A qualitative assessment of Louisiana health disparities collaboratives
por: Joshi, Praphul, et al.
Publicado: (2012)

The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
por: Finney, Alexandra C., et al.
Publicado: (2023)

Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index
por: Khera, Rohan, et al.
Publicado: (2020)

An asthma collaboration to reduce childhood asthma disparities on the Navajo Nation: Trial protocol for the Community Asthma Program
por: Lowe, A.A., et al.
Publicado: (2022)

COVID-19: RACIAL DISPARITY AND CARDIOVASCULAR COMORBIDITIES THAT PREDICT MORTALITY
por: Omeh, Demian Jideofor, et al.
Publicado: (2021)

Burden of Disease of COVID-19: Strengthening the Collaboration for National Studies
por: Pires, Sara Monteiro, et al.
Publicado: (2022)

Carotid Atherosclerosis, Microalbuminuria, and Estimated 10-Year Atherosclerotic Cardiovascular Disease Risk in Sub-Saharan Africa
por: Nonterah, Engelbert A., et al.
Publicado: (2022)

Ethnic disparities in estimated cardiovascular disease risk in Amsterdam, the Netherlands: The HELIUS study
por: Perini, W., et al.
Publicado: (2018)

Severe Hypoglycemia and Risk of Atherosclerotic Cardiovascular Disease in Patients With Diabetes
por: Rana, Jamal S., et al.
Publicado: (2021)

Cardiovascular Imaging for the Primary Prevention of Atherosclerotic Cardiovascular Disease Events
por: Weber, Lauren A., et al.
Publicado: (2015)

Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System
por: Vassy, Jason L., et al.
Publicado: (2020)

Effect of DASH Diet Versus Healthy Dietary Advice on the Estimated Atherosclerotic Cardiovascular Disease Risk
por: Said, Marwa S., et al.
Publicado: (2021)

Evaluating algorithmic fairness in the presence of clinical guidelines: the case of atherosclerotic cardiovascular disease risk estimation
por: Foryciarz, Agata, et al.
Publicado: (2022)

Polypill for atherosclerotic cardiovascular disease prevention in Haiti: Eligibility estimates in a low-income country
por: Yan, Lily D., et al.
Publicado: (2022)

Ethnic Disparities in Atherosclerotic Cardiovascular Disease Incidence and Prevalence Among Rheumatoid Arthritis Patients in the United States: a Systematic Review
por: Daniel, Christina M., et al.
Publicado: (2020)

Androgen therapy and atherosclerotic cardiovascular disease
por: McGrath, K-CY, et al.
Publicado: (2008)

Atherosclerotic Cardiovascular Disease Beginning in Childhood
por: Hong, Young Mi
Publicado: (2010)

The gut microbiome in atherosclerotic cardiovascular disease
por: Jie, Zhuye, et al.
Publicado: (2017)

COVID-19 in Solid Organ Transplantation: Results of the National COVID Cohort Collaborative
por: Vinson, Amanda J., et al.
Publicado: (2021)

Coronavirus Disease 2019 (COVID-19) set to increase burden of atherosclerotic cardiovascular disease in Kenya
por: Ogeng’o, Julius, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sma89gi1930i9bq90q6ncccs84